Active, Not Recruiting
Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer
NCT02827877
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 Positive Breast Carcinoma, +7 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States